Pre- and post-transplant treatment of hepatitis C.
Gane
E
E
NZ Liver Transplant Unit, Auckland Hospital, New Zealand. e.gane@auckland.ac.nz
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000628:therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D016031:Liver Transplantation; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012254:Ribavirin